Caris Life Sciences (CAI) Current Assets (2024 - 2026)

Caris Life Sciences' Current Assets history runs 3 years deep, the most recent figure standing at $1.0 billion for Q1 2026.

• On a quarterly basis, Current Assets changed N/A year-over-year to $1.0 billion in Q1 2026; TTM through Mar 2026 was $1.0 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $997.8 million, up 362.52% from the prior year.
• Current Assets climbed to $1.0 billion in Q1 2026 per CAI's latest filing, from $997.8 million in the prior quarter.
• Across five years, Current Assets topped out at $1.0 billion in Q1 2026 and bottomed at $215.7 million in Q4 2024.
• The 3-year median for Current Assets is $854.2 million (2025), against an average of $783.1 million.
• Biggest YoY gain for Current Assets was 362.52% in 2025; the steepest drop was 362.52% in 2025.
• Year by year, Current Assets stood at $215.7 million in 2024, then surged by 362.52% to $997.8 million in 2025, then climbed by 1.64% to $1.0 billion in 2026.
• Per Business Quant, the three latest CAI Current Assets figures stand at $1.0 billion (Q1 2026), $997.8 million (Q4 2025), and $854.2 million (Q3 2025).